Convoke
PrivateLast Round
Seed
Aug 19, 2025
Total Funding Raised
$8.6M
Company Overview
Convoke operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Seed round in August 2025.
Convoke is a biotechnology software company that provides an AI-native operating system designed to streamline drug development and commercialization workflows for biopharmaceutical companies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Workflow Automation, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Convoke Comparables
Compare Convoke with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cheiron | 86% | |
| Narrativa | 75% | |
| Peer AI | 74% |
For institutional investors. Book with your work email.
Convoke Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Convoke Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Audacious Ventures | Seed |
| SNR | Seed |
| Lux Capital | Seed |
| Not Boring Capital | Seed |
| Thales Partners - Consultoria de Investimentos | Seed |
| Sherpa Capital | Seed |
| Comma Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 64% MoM, reaching 10.2K.
- Mar 5, 2026
Monthly visitors increased 65% MoM, reaching 6.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 31, 2026
Convoke launches Competitive Intelligence (CI) Monitoring in its free drug database on Aug 31st '26, letting users track publications, clinical trials, corporate announcements, patents and financial filings across selected diseases or targets, with access at platform.convoke.bio and alerts via email or Slack.
For institutional investors. Book with your work email.
Convoke Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Convoke's valuation, stock price, and market status.
Is Convoke a public or private company?
Convoke is a private company.
What is the current stock price of Convoke?
Convoke is a private company, so its shares have no public market price. Caplight tracks Convoke's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Convoke worth (valuation)?
Valuation information for Convoke is not publicly available.
Can I buy Convoke stock?
Convoke shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Convoke's last funding round?
Convoke's most recent funding round was Seed on August 19, 2025.
Who are the main investors in Convoke?
Key investors in Convoke include Dimension, Kleiner Perkins.
Will Convoke IPO soon?
No public IPO plans have been announced for Convoke.
How can I track Convoke secondary market activity?
Caplight tracks bids, offers, and trades in Convoke's shares on secondary markets.